Anti-CD20 therapy reduces lesion volume and activated microglia in rodent models of multiple sclerosis - ORA - Oxford University Research Archive

Back to Search

Conference item

Anti-CD20 therapy reduces lesion volume and activated microglia in rodent models of multiple sclerosis

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Seneca, N., Campbell, S., Balazs, M., Leppert, D., & Anthony, D. (2016). Anti-CD20 therapy reduces lesion volume and activated microglia in rodent models of multiple sclerosis. 32, S58–S59.

MLA Style

Seneca, N., et al. Anti-CD20 Therapy Reduces Lesion Volume and Activated Microglia in Rodent Models of Multiple Sclerosis. 2016, pp. S58–S59.

Chicago Style

Seneca, N, S Campbell, M Balazs, D Leppert, and D Anthony. 2016. “Anti-CD20 Therapy Reduces Lesion Volume and Activated Microglia in Rodent Models of Multiple Sclerosis.” In , 32:S58–S59.
Tweet
Print

Authors

+ Seneca, N More by this author

Role:

Author

+ Campbell, S More by this author

Role:

Author

+ Balazs, M More by this author

Role:

Author

+ Leppert, D More by this author

Role:

Author

+ Anthony, D More by this author

Institution:

University of Oxford

Division:

MSD

Department:

Pharmacology

Role:

Author

Bibliographic Details

Volume:: 32
Pages:: S58-S59
Host title:: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Publication date:: 2012-08-01
ISSN:: 0271-678X
Source identifiers:: 350770

Item Description

Pubs id:: pubs:350770
UUID:: uuid:c9cc4419-bf17-4c62-9a0f-1fbfc7ca00cc
Local pid:: pubs:350770
Deposit date:: 2013-11-16

Terms of use

Copyright date:: 2012

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Metrics

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP